Abstract
Selection of treatment for non-melanoma skin cancer (NMSC) takes into account many factors, including different host, tumor and treatment factors. Examples of these factors are presented. Ultimately the treatment decision is affected by the availability of surgical, dermatological, radiotherapeutic expertise and supportive resources. Different treatment options are discussed in this review. After appropriate education and guidance, patients' wish should take the first priority. The treatment of skin cancer requires experience, and discussion in multidisciplinary team meetings is strongly encouraged.
Keywords: Chemotherapy, cryosurgery, electrodessication and curettage, plastic surgery, radiotherapy, skin, surgery.
Current Cancer Therapy Reviews
Title:Treatment Decisions for Non-Melanoma Skin Cancer (NMSC)
Volume: 12 Issue: 2
Author(s): Khanh Vu, Patricia Tai, Arbind Dubey, Rashmi Koul and Elizabeth A. Barnes
Affiliation:
Keywords: Chemotherapy, cryosurgery, electrodessication and curettage, plastic surgery, radiotherapy, skin, surgery.
Abstract: Selection of treatment for non-melanoma skin cancer (NMSC) takes into account many factors, including different host, tumor and treatment factors. Examples of these factors are presented. Ultimately the treatment decision is affected by the availability of surgical, dermatological, radiotherapeutic expertise and supportive resources. Different treatment options are discussed in this review. After appropriate education and guidance, patients' wish should take the first priority. The treatment of skin cancer requires experience, and discussion in multidisciplinary team meetings is strongly encouraged.
Export Options
About this article
Cite this article as:
Vu Khanh, Tai Patricia, Dubey Arbind, Koul Rashmi and Barnes A. Elizabeth, Treatment Decisions for Non-Melanoma Skin Cancer (NMSC), Current Cancer Therapy Reviews 2016; 12 (2) . https://dx.doi.org/10.2174/1573394712666160921151835
DOI https://dx.doi.org/10.2174/1573394712666160921151835 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Review of Techniques for Gene Therapy in Bone Healing
Current Stem Cell Research & Therapy Innate Immune System Modulation During Aging: Contributions of Macrophages and Dendritic Cells
Current Immunology Reviews (Discontinued) Enhanced Activity of pSTAT-3 Ser-727 in Functional Endothelial Cells Under Calcifying Conditions
Current Chemical Biology Targeting Hsp90 in Non-Cancerous Maladies
Current Topics in Medicinal Chemistry Cyclodextrins and their Derivatives as Carrier Molecules in Drug and Gene Delivery Systems
Current Organic Chemistry Molecular Aspects of Resistance to Biological and Non-Biological Drugs and Strategies to Overcome Resistance in Colorectal Cancer
Current Medicinal Chemistry Cinnamic Acid Derivatives as Anticancer Agents-A Review
Current Medicinal Chemistry Integrins in Drug Targeting-RGD Templates in Toxins
Current Pharmaceutical Design Anticancer Drug-Induced Immunomodulation and Cancer Therapeutics
Current Cancer Therapy Reviews Nasal Polyposis: An Overview of Differential Diagnosis and Treatment
Recent Patents on Inflammation & Allergy Drug Discovery Progress in Topical siRNA Delivery Approaches for Skin Disorders
Current Pharmaceutical Design Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Current Pharmaceutical Design Therapeutic Potential of microRNA Against Th2-associated Immune Disorders
Current Topics in Medicinal Chemistry Biologic Therapies in Primary Sjögren's Syndrome
Current Pharmaceutical Biotechnology Notch Inhibitors as a New Tool in the War on Cancer: A Pathway to Watch
Current Pharmaceutical Biotechnology Statins and Alkylphospholipids as New Anticancer Agents Targeting Lipid Metabolism
Anti-Cancer Agents in Medicinal Chemistry Development of Liposomes and Pseudovirions with Fusion Activity for Efficient Gene Delivery
Current Gene Therapy Antiproliferative Activity of Cobra Venom Cytotoxins
Current Topics in Medicinal Chemistry Chitosan Formulations as Carriers for Therapeutic Proteins
Current Drug Discovery Technologies Silibinin – A Promising New Treatment for Cancer
Anti-Cancer Agents in Medicinal Chemistry